Close Menu

NEW YORK (360Dx) — A combination of three biomarkers — two blood-based peptides and one genetic risk factor — can accurately predict abnormal accumulation of beta-amyloid plaques in the brains of living Alzheimer's disease patients, according to a study published online today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.